Emergent BioSolutions Inc.EBSNYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+4.0%
5Y CAGR-15.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+4.0%/yr
vs -28.3%/yr prior
5Y CAGR
-15.4%/yr
Recent acceleration
Acceleration
+32.3pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.38 | +33.3% |
| 2024 | 1.04 | +25.0% |
| 2023 | 0.83 | -32.5% |
| 2022 | 1.23 | -16.7% |
| 2021 | 1.48 | -53.6% |
| 2020 | 3.18 | +2.2% |
| 2019 | 3.12 | -33.2% |
| 2018 | 4.67 | +47.2% |
| 2017 | 3.17 | +17.7% |
| 2016 | 2.69 | - |